![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
OncoArendi Therapeutics to Begin the Phase 1 Clinical Evaluation of its Novel Class of Medicines
OncoArendi Therapeutics announced today that this week the Company will initiate a Phase 1 study designed to assess the safety, tolerability and pharmacokinetics of...
Clinical Trials
ABIVAX’s ABX464 Reduces HIV Reservoir in Blood in Second Phase 2a Clinical Trial
ABIVAX an innovative biotechnology company targeting the immune system to eliminate viral diseases using its unique technology platform announced top-line results from the first...
Clinical Trials
In Preclinical Trials Inovio dMAb™ Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial Infection
Inovio Pharmaceuticals, Inc. announced that the development of its DNA-based monoclonal antibody program received a boost from two peer-reviewed scientific papers that demonstrate their...
Clinical Trials
Datavant to Improve Clinical Trials with Artificial Intelligence launched by Roivant Sciences
Roivant Sciences, a global healthcare company focused on realizing the full value of promising biomedical research to improve the lives of patients and their...
Clinical Trials
Results of Subpopulation Analysis of Patients with Hepatitis B Virus Coinfection
Eisai Co., Ltd. has announced that the results of a subpopulation analysis of patients with hepatitis B virus (HBV) coinfection in a Phase III...
Clinical Trials
Clinical studies with a new compound –PM14- in patients with solid tumors started by PharmaMar
With the motivation of finding a solution to the unmet needs of patients with different types of cancer, PharmaMar (MSE:PHM) announces the start of...
Clinical Trials
Levicept Starts First-in-Human Phase I Trial of LEVI-04, A Novel Fusion Protein Therapy for Chronic Pain
Levicept Ltd., an asset-centric biotechnology company focused on the development of LEVI-04, a first-in-class treatment for chronic pain indications announces that it has commenced...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read